These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29229440)

  • 1. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
    Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.
    Molina JM; Bercot B; Assoumou L; Rubenstein E; Algarte-Genin M; Pialoux G; Katlama C; Surgers L; Bébéar C; Dupin N; Ouattara M; Slama L; Pavie J; Duvivier C; Loze B; Goldwirt L; Gibowski S; Ollivier M; Ghosn J; Costagliola D;
    Lancet Infect Dis; 2024 Oct; 24(10):1093-1104. PubMed ID: 38797183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    Luetkemeyer AF; Donnell D; Dombrowski JC; Cohen S; Grabow C; Brown CE; Malinski C; Perkins R; Nasser M; Lopez C; Vittinghoff E; Buchbinder SP; Scott H; Charlebois ED; Havlir DV; Soge OO; Celum C;
    N Engl J Med; 2023 Apr; 388(14):1296-1306. PubMed ID: 37018493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
    Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM;
    N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials.
    Szondy I; Meznerics FA; Lőrincz K; Kemény LV; Walter A; Mohammed AA; Hegyi P; Kiss N; Bánvölgyi A
    Int J Infect Dis; 2024 Oct; 147():107186. PubMed ID: 39122208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
    Van Dijck C; Tsoumanis A; Rotsaert A; Vuylsteke B; Van den Bossche D; Paeleman E; De Baetselier I; Brosius I; Laumen J; Buyze J; Wouters K; Lynen L; Van Esbroeck M; Herssens N; Abdellati S; Declercq S; Reyniers T; Van Herrewege Y; Florence E; Kenyon C
    Lancet Infect Dis; 2021 May; 21(5):657-667. PubMed ID: 33676596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.
    Cornelisse VJ; Riley B; Medland NA
    Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants.
    Fredericksen RJ; Perkins R; Brown CE; Cannon C; Lopez C; Cohee A; Dombrowski JC; Cohen S; Malinski C; Powell M; Luetkemeyer AF; Celum C; Christopoulos K
    AIDS Patient Care STDS; 2024 Apr; 38(4):155-167. PubMed ID: 38656217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
    Buchbinder SP; Glidden DV; Liu AY; McMahan V; Guanira JV; Mayer KH; Goicochea P; Grant RM
    Lancet Infect Dis; 2014 Jun; 14(6):468-75. PubMed ID: 24613084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study.
    Torres Silva MS; Torres TS; Coutinho C; Ismério Moreira R; da Costa Leite I; Cunha M; da Costa Leite PHA; Cáceres CF; Vega-Ramírez H; Konda KA; Guanira J; Valdez Madruga J; Wagner Cardoso S; Benedetti M; Pimenta MC; Hoagland B; Grinsztejn B; Gonçalves Veloso V;
    Lancet HIV; 2024 Oct; 11(10):e670-e679. PubMed ID: 39243787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
    Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
    Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Pre-exposure Prophylaxis Trial.
    Berçot B; Charreau I; Rousseau C; Delaugerre C; Chidiac C; Pialoux G; Capitant C; Bourgeois-Nicolaos N; Raffi F; Pereyre S; Le Roy C; Senneville E; Meyer L; Bébéar C; Molina JM;
    Clin Infect Dis; 2021 Oct; 73(7):e2127-e2133. PubMed ID: 33305785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ogbuagu O; Ruane PJ; Podzamczer D; Salazar LC; Henry K; Asmuth DM; Wohl D; Gilson R; Shao Y; Ebrahimi R; Cox S; Kintu A; Carter C; Das M; Baeten JM; Brainard DM; Whitlock G; Brunetta JM; Kronborg G; Spinner CD;
    Lancet HIV; 2021 Jul; 8(7):e397-e407. PubMed ID: 34197772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
    Molina JM; Capitant C; Spire B; Pialoux G; Cotte L; Charreau I; Tremblay C; Le Gall JM; Cua E; Pasquet A; Raffi F; Pintado C; Chidiac C; Chas J; Charbonneau P; Delaugerre C; Suzan-Monti M; Loze B; Fonsart J; Peytavin G; Cheret A; Timsit J; Girard G; Lorente N; Préau M; Rooney JF; Wainberg MA; Thompson D; Rozenbaum W; Doré V; Marchand L; Simon MC; Etien N; Aboulker JP; Meyer L; Delfraissy JF;
    N Engl J Med; 2015 Dec; 373(23):2237-46. PubMed ID: 26624850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do not overuse doxycycline as prophylaxis for uncomplicated sexually transmitted infections].
    Filén F; Eriksen J; Missailidis C
    Lakartidningen; 2024 Aug; 121():. PubMed ID: 39101261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.